Clinical Trial

NIRAF-Guided Parathyroid Identification During Thyroidectomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-site, two-component prospective study evaluating whether near-infrared autofluorescence (NIRAF) imaging can improve intraoperative identification of parathyroid glands during thyroidectomy and reduce postoperative hypocalcemia. The investigational platform is a modified wearable stereoscopic goggle system configured for label-free NIRAF imaging. Parathyroid tissue is excited with near-infrared light at approximately 780 nm and emits autofluorescence centered near 800 nm. No injected dye or external contrast agent is used. The goggles are used only during a brief mapping interval after thyroid exposure and for ex vivo interrogation of the resected thyroid specimen. Component A is a prospective observational run-in validation cohort of 30 adults undergoing thyroidectomy of any extent. NIRAF-positive foci on the intact thyroidectomy specimen are suture-marked and correlated with targeted pathology. Component B is a randomized clinical study of 250 adults undergoing total or completion thyroidectomy. Participants are randomized 1:1 to standard surgery or standard surgery plus brief in vivo NIRAF mapping, ex vivo specimen interrogation, and rescue autotransplantation when indicated. The primary outcome for Component B is transient biochemical hypocalcemia on postoperative day 1, defined using albumin-corrected serum calcium.
Trial Details
NCT Number NCT07617584
Lead Sponsor Ss. Cyril and Methodius University of Skopje
Collaborators: University of Illinois at Urbana-Champaign
Conditions Hypocalcemia, Hypoparathyroidism, Thyroid Diseases, Goiter, Nodular, Thyroid Nodule, Thyroidectomy
Enrollment 280 participants
Start Date 2026-06-01
Primary Completion 2029-06-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-01